Characterization vitro chemosensitivity perioperative human ovarian malignancies adenosine triphosphate chemosensitivity vitro chemosensitivity primary recurrent human ovarian tumor samples adenosine triphosphate chemosensitivity sensitivity equal decrease intracellular adenosine triphosphate versus control peak plasma concentration agent assays Single-agent dose-response patterns viability drug concentration Thirteen primary tumors sensitive sensitive sensitive combination Seven recurrent tumors sensitive sensitive sensitive combination Dose-response characteristics vitro sensitivity rates article consistent reports patient response literature adenosine triphosphate chemosensitivity assay efficient reliable instrument vitro chemosensitivity assessment human tumors warrants clinical investigation 